MONDAY, Sept. 8, 2025 -- The addition of baxdrostat, an aldosterone synthase inhibitor, to background therapy yields a significant reduction in seated...
Vous n'êtes pas connecté
MONDAY, Sept. 8, 2025 -- The addition of baxdrostat, an aldosterone synthase inhibitor, to background therapy yields a significant reduction in seated systolic blood pressure among patients with uncontrolled or resistant hypertension, according to a...
MONDAY, Sept. 8, 2025 -- The addition of baxdrostat, an aldosterone synthase inhibitor, to background therapy yields a significant reduction in seated...
MONDAY, Sept. 15, 2025 -- For patients with rheumatoid arthritis (RA), methotrexate significantly reduces systolic blood pressure (SBP), according to...
MONDAY, Sept. 8, 2025 — A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the...
MONDAY, Sept. 8, 2025 — A novel pill that blocks the hormone aldosterone shows promise for lowering blood pressure and potentially delaying the...
Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of kidney disease in people with...
TUESDAY, Sept. 9, 2025 -- Few online stock photo images of blood pressure (BP) measurement align with clinical guidelines, according to a study...
TUESDAY, Sept. 9, 2025 -- Few online stock photo images of blood pressure (BP) measurement align with clinical guidelines, according to a study...
THURSDAY, Sept. 4, 2025 — An experimental pill might help people with stubborn high blood pressure that won’t relent to other treatments,...
FRIDAY, Sept. 12, 2025 -- Higher blood pressure (BP) at age 7 years is associated with an increased risk for premature cardiovascular disease (CVD)...
FRIDAY, Sept. 12, 2025 -- Higher blood pressure (BP) at age 7 years is associated with an increased risk for premature cardiovascular disease (CVD)...